On the development, Wockhardt Group Founder Chairman Habil Khorakiwala said Wockhardt has been at the forefront in the fight against Anti-Microbial Resistance (AMR) which has been identified as one of the top threats by WHO.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/38cAp0b
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Wockhardt, Jemincare partner for novel respiratory antibiotic Nafithromycin
0 comments:
Post a Comment